Gilead Sciences Inc buy Deutsche Bank Aktiengesellschaft
Start price
18.02.25
/
50%
€99.69
Target price
18.02.26
€114.86
Performance (%)
29.52%
End price
19.02.26
€129.12
Summary
This prediction ended on 19.02.26 with a price of €129.12. The prediction had a final performance of 29.52%. A total of €3.16 was paid as dividends for this prediction. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Gilead Sciences Inc | 4.041% | 4.041% | 18.628% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences, Inc. (NASDAQ: GILD) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating. They now have a $120.00 price target on the stock, up previously from $80.00.
Ratings data for GILD provided by MarketBeat
In the thread Trading Gilead Sciences Inc
Die von Deutsche_Bank_Aktien gewählte maximale Laufzeit wurde überschritten